VISKASE CORPORATION – Trademark Portfolio
Entity Type: 03
VISKASE CORPORATION owns a portfolio of 48 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as VISLON, VISMAX, VISFLEX, VISKASE, and E-Z PEEL. Of these, 13 are registered. The portfolio spans 9 Nice Classification classes, led by Class 18 (Leather Goods) and Class 16 (Paper Goods). Headquartered in Darien, IL.
8205 S. Cass Avenue, Suite 115
Darien, IL 60561
Showing of trademarks Trademarks
Trademark Classifications
VISKASE CORPORATION's trademark portfolio spans 9 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Machines and machine tools; motors and engines; machine coupling and transmission components
Frequently Asked Questions
How many trademarks does VISKASE CORPORATION have?
VISKASE CORPORATION has 48 U.S. trademarks filed with the USPTO. Of these, 13 registered, 6 abandoned, 29 cancelled.
What trademark classes does VISKASE CORPORATION file in?
VISKASE CORPORATION files trademarks across 9 Nice Classification classes. The most active classes are Class 18 (Leather Goods), Class 16 (Paper Goods), Class 17 (Rubber Goods), Class 7 (Machinery), Class 10 (Medical Apparatus). Class 18 covers leather and imitations of leather; animal skins, hides; trunks and travelling bags.
What are VISKASE CORPORATION's most well-known trademarks?
VISKASE CORPORATION's registered trademark portfolio includes well-known marks such as VISLON, VISMAX, VISFLEX, VISKASE, and E-Z PEEL. These are among 13 currently registered trademarks in the portfolio.
What is VISKASE CORPORATION's trademark registration success rate?
VISKASE CORPORATION has a 27% trademark registration rate, with 13 out of 48 resolved applications resulting in successful registration. Currently, 0 applications are pending review.